二尖瓣輪形成術設備的開發平台 - 開發階段，市場區隔，地區和國家，法規途徑，主要企業(2024年版)

Mitral Valve Annuloplasty Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: 2024年06月13日 | 出版商:

GlobalData | 英文 54 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

二尖瓣輪形成術設備，與二尖瓣的修復所使用的環狀成形術術環用帶被構成。

本報告提供二尖瓣輪形成術設備市場相關調查，提供產品概要與正在開發的開發中產品趨勢，各種處於開發階段產品的比較分析和進行中的臨床試驗相關資訊，及參與企業的最近的趨勢等資訊。

Affluent Medical SASU
Anchorvalve
Boston Scientific Corp
CUBE SRL
HVR Cardio Oy
MiCardia Corp
Michigan Critical Care Consultants Inc
Millipede LLC
Mitre Medical Corp
Rambam Health Care Campus
Syntach AB
Tau Pnu Medical Co., Ltd.
TransCardiac Therapeutics, LLC
Transmural systems LLC
TTK Healthcare Ltd
Valcare Medical
Valtech Cardio Ltd

第6章二尖瓣輪形成術設備-最近的趨勢

第7章附錄

簡介目錄

Product Code: GDME1759EPD

GlobalData's Medical Devices sector report, "Mitral Valve Annuloplasty Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Mitral Valve Annuloplasty Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Mitral Valve Annuloplasty Devices consist of the annuloplasty rings and bands that are used in the repair of mitral valves.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Mitral Valve Annuloplasty Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Mitral Valve Annuloplasty Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Mitral Valve Annuloplasty Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Mitral Valve Annuloplasty Devices Overview

3 Products under Development

3.1 Mitral Valve Annuloplasty Devices - Pipeline Products by Stage of Development
3.2 Mitral Valve Annuloplasty Devices - Pipeline Products by Territory
3.3 Mitral Valve Annuloplasty Devices - Pipeline Products by Regulatory Path
3.4 Mitral Valve Annuloplasty Devices - Pipeline Products by Estimated Approval Date
3.5 Mitral Valve Annuloplasty Devices - Ongoing Clinical Trials

4 Mitral Valve Annuloplasty Devices - Pipeline Products under Development by Companies

4.1 Mitral Valve Annuloplasty Devices Companies - Pipeline Products by Stage of Development
4.2 Mitral Valve Annuloplasty Devices - Pipeline Products by Stage of Development

5 Mitral Valve Annuloplasty Devices Companies and Product Overview

5.1 Affluent Medical SASU Company Overview
- 5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anchorvalve Company Overview
- 5.2.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
- 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 CUBE SRL Company Overview
- 5.4.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview
5.5 HVR Cardio Oy Company Overview
- 5.5.1 HVR Cardio Oy Pipeline Products & Ongoing Clinical Trials Overview
5.6 MiCardia Corp Company Overview
- 5.6.1 MiCardia Corp Pipeline Products & Ongoing Clinical Trials Overview
5.7 Michigan Critical Care Consultants Inc Company Overview
- 5.7.1 Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Millipede LLC Company Overview
- 5.8.1 Millipede LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Mitre Medical Corp Company Overview
- 5.9.1 Mitre Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Rambam Health Care Campus Company Overview
- 5.10.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview
5.11 Syntach AB Company Overview
- 5.11.1 Syntach AB Pipeline Products & Ongoing Clinical Trials Overview
5.12 Tau Pnu Medical Co., Ltd. Company Overview
- 5.12.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.13 TransCardiac Therapeutics, LLC (Inactive) Company Overview
- 5.13.1 TransCardiac Therapeutics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 Transmural systems LLC Company Overview
- 5.14.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 TTK Healthcare Ltd Company Overview
- 5.15.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Valcare Medical Company Overview
- 5.16.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
5.17 Valtech Cardio Ltd Company Overview
- 5.17.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Mitral Valve Annuloplasty Devices- Recent Developments

6.1 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
6.2 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
6.3 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study
6.4 Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results
6.5 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
6.6 Apr 22, 2024: Genesee BioMedical Receives FDA 510(k) Clearance for TransForm McCarthy Mitral Annuloplasty Ring (TF)
6.7 Apr 15, 2024: Edwards Lifesciences Appoints New China Head
6.8 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
6.9 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
6.10 Jan 15, 2024: Affluent Medical : Pre-submission Dossier for the 510(K) of Medical Device Kaliostm Filed With FDA for Review
6.11 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
6.12 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
6.13 Sep 13, 2023: Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities
6.14 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
6.15 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
6.16 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024